CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
94 hedge funds and large institutions have $132M invested in Concert Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 37
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
94
Holding in Top 10
1
Calls
$160K
Puts
$20K
Top Buyers
| 1 | +$3.35M | |
| 2 | +$2.73M | |
| 3 | +$1.64M | |
| 4 |
SCA
Secor Capital Advisors
New York
|
+$740K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$606K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$2.12M | |
| 3 | -$1.69M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.55M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.48M |